146 related articles for article (PubMed ID: 8701821)
1. Carcinoma of the prostate: treatment of bone metastasis.
Scalliet P
Acta Urol Belg; 1996 May; 64(2):87-90. PubMed ID: 8701821
[No Abstract] [Full Text] [Related]
2. Treatment options in androgen-independent prostate cancer.
Lara PN; Meyers FJ
Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
[TBL] [Abstract][Full Text] [Related]
3. A case of orbital metastasis from prostatic carcinoma as an initial symptom.
Isshiki S; Cho S; Matsuno D; Sato N; Furuya Y
Hinyokika Kiyo; 2007 Mar; 53(3):193-5. PubMed ID: 17447492
[TBL] [Abstract][Full Text] [Related]
4. Hemibody irradiation in advanced prostatic carcinoma.
Kuban DA; Schellhammer PF; el-Mahdi AM
Urol Clin North Am; 1991 Feb; 18(1):131-7. PubMed ID: 1704159
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic prostate adenocarcinoma to the calcaneus.
Bibbo C; Hatfield SP; Albright JT
J Foot Ankle Surg; 2010; 49(2):159.e15-20. PubMed ID: 20015665
[TBL] [Abstract][Full Text] [Related]
6. Prolonged survival with metastatic prostate cancer to bone.
Pisters LL; Troncoso P; Navone N
J Urol; 1998 Jun; 159(6):2100. PubMed ID: 9598540
[No Abstract] [Full Text] [Related]
7. Preservation of bone health in prostate cancer.
Lattouf JB; Saad F
Curr Opin Support Palliat Care; 2007 Oct; 1(3):192-7. PubMed ID: 18685362
[TBL] [Abstract][Full Text] [Related]
8. [Medical treatment of bone metastases].
Tubiana-Hulin M
Bull Cancer Radiother; 1996; 83(4):299-304. PubMed ID: 9081331
[No Abstract] [Full Text] [Related]
9. [Loss of differentiation of a prostate adenocarcinoma after hormone therapy: the example of a metastasis in the spongy body of the penis].
Uphoff J; Woziwodzki J; Schattka SO; Kollias A
Aktuelle Urol; 2008 Sep; 39(5):373-7. PubMed ID: 18798127
[TBL] [Abstract][Full Text] [Related]
10. Management options for painful carcinoma of the prostate.
Chisholm GD; Rana A; Howard GC
Semin Oncol; 1993 Jun; 20(3 Suppl 2):34-7. PubMed ID: 7684864
[No Abstract] [Full Text] [Related]
11. Challenging problems in advanced malignancy: Case 2. Disseminated intravascular coagulation in metastatic hormone-refractory prostate cancer.
Kampel LJ
J Clin Oncol; 2003 Aug; 21(16):3170-1. PubMed ID: 12915609
[No Abstract] [Full Text] [Related]
12. [Diferelin treatment of primary local and generalized cancer of the prostate].
Kolesnikov GP; Rusakov IG; Shaplygin LV; Voznesenskiĭ SA; Bystrov AA
Urologiia; 2001; (6):17-9. PubMed ID: 11785073
[No Abstract] [Full Text] [Related]
13. Palliative embolization in bone metastasis of hypernephroma using oily contrast-labeled gel.
Weber J
Ann Radiol (Paris); 1982 Nov; 25(7):460-2. PubMed ID: 6187261
[No Abstract] [Full Text] [Related]
14. Use of a modified hemi-body irradiation technique for metastatic carcinoma of the prostate: report of a 10-year experience.
Bashir FA; Parry JM; Windsor PM
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):591-8. PubMed ID: 18562185
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer presenting with normal serum PSA levels and boney metastases treated with zoledronic acid.
Mystakidou K; Katsouda E; Parpa E; Vlahos L
J Pain Palliat Care Pharmacother; 2005; 19(3):41-5. PubMed ID: 16219610
[TBL] [Abstract][Full Text] [Related]
16. Initial therapy of advanced prostate cancer.
Ismail M; Gomella LG
Compr Ther; 1997 Oct; 23(10):649-55. PubMed ID: 9327180
[No Abstract] [Full Text] [Related]
17. Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.
Amato RJ; Hernandez-McClain J; Henary H
Am J Clin Oncol; 2008 Dec; 31(6):532-8. PubMed ID: 19060583
[TBL] [Abstract][Full Text] [Related]
18. [Hypnosis as an alternative treatment for pain in palliative medicine].
Peintinger C; Hartmann W
Wien Med Wochenschr; 2008; 158(23-24):674-9. PubMed ID: 19165446
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of advanced prostate cancer].
Leisinger HJ; Jichlinski P
Rev Med Suisse Romande; 1999 Jun; 119(6):507-11. PubMed ID: 10422478
[No Abstract] [Full Text] [Related]
20. Current strategies in the treatment of metastatic hormone-refractory prostate cancer.
Ghosn M; Kattan J; Younes F
Tunis Med; 2005 Dec; 83 Suppl 12():74. PubMed ID: 16430073
[No Abstract] [Full Text] [Related]
[Next] [New Search]
